Achieve Life Sciences
ACHV
ACHV
70 hedge funds and large institutions have $57.5M invested in Achieve Life Sciences in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
70
Holders Change
+6
Holders Change %
+9.38%
% of All Funds
0.93%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
11
Increased
27
Reduced
12
Closed
4
Calls
$2.43M
Puts
$2K
Net Calls
+$2.42M
Net Calls Change
+$720K
Top Buyers
1 |
DI
DUMAC Inc
Durham,
North Carolina
|
$176K |
2 |
![]()
JPMorgan Chase & Co
New York
|
$209K |
3 |
Northern Trust
Chicago,
Illinois
|
$1.47M |
4 |
UBS Group
Zurich,
Switzerland
|
$184K |
5 |
Citadel Advisors
Miami,
Florida
|
$112K |
Top Sellers
1 |
SC
Shay Capital
New York
|
$88K |
2 |
SI
Sofinnova Investments
Menlo Park,
California
|
$4.6M |
3 |
Vanguard Group
Malvern,
Pennsylvania
|
$6.16M |
4 |
Goldman Sachs
New York
|
$532K |
5 |
![]()
Alyeska Investment Group
Chicago,
Illinois
|
$1.48M |